MALIGNANT TUMORS
Clinical trials for MALIGNANT TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis study tests an experimental drug called LM-364, given alone or with another cancer drug (tislelizumab), in people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 90 adults…
Matched conditions: MALIGNANT TUMORS
Phase: PHASE1, PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Smart scans may boost power of radioactive seeds against cancer
Disease control Not yet recruitingThis study tests whether using PET/CT scans to guide radioactive seed placement can better target and kill tumors in people with solid cancers. About 90 adults will be assigned to one of three planning methods: standard CT, PET/CT with standard dose, or PET/CT with a biologically…
Matched conditions: MALIGNANT TUMORS
Phase: NA • Sponsor: Li Min • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Radiation and immunotherapy join forces in new cancer trial
Disease control Not yet recruitingThis study tests whether adding a special type of radiation (called 125I seed brachytherapy) to standard immunotherapy can help shrink tumors and keep them from growing back. The trial will include 90 adults with various cancers that have come back or spread. Half will get the co…
Matched conditions: MALIGNANT TUMORS
Phase: PHASE2 • Sponsor: Li Min • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Gut check: could your microbiome predict fertility after immunotherapy?
Knowledge-focused Not yet recruitingThis observational study looks at how immune checkpoint inhibitors (a type of cancer immunotherapy) affect ovarian function and fertility in women aged 18-38 with solid tumors. Researchers will collect blood and stool samples before and during treatment to measure hormone levels …
Matched conditions: MALIGNANT TUMORS
Sponsor: West China Second University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC